Companies / Aveo Pharmaceuticals, Inc.
Aveo Pharmaceuticals, Inc.
AVEOCIK 1325879
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 19, 2023 | Bailey Michael P CEO | Other Sold to issuer | Common Stock | $5.00M | -333K -100.00% | 0 | low |
| Jan 19, 2023 | Evnin Anthony B Director | Other Sold to issuer | Common Stock | $627.6K | -42K -100.00% | 0 | low |
| Dec 20, 2022 | Bailey Michael P CEO | Exercise Option exercise | Common Stock | $603.8K | +165K +93.67% | 340,167 | low |
| Dec 20, 2022 | Bailey Michael P CEO | Exercise Option exercise | Common Stock | $480.0K | +86K +95.33% | 175,642 | low |
| Jan 19, 2023 | Ferraresso Michael Executive | Other Sold to issuer | Common Stock | $245.2K | -16K -100.00% | 0 | low |
| Dec 20, 2022 | Bailey Michael P CEO | Exercise Option exercise | Common Stock | $164.3K | +26K +46.97% | 82,920 | low |
| Sep 1, 2021 | Bailey Michael P CEO | Buy Open-market buy | Common Stock | $97.2K | +15K +43.72% | 49,311 | medium |
| Aug 10, 2021 | Ferraresso Michael Executive | Buy Open-market buy | Common Stock | $15.0K | +3K +45.67% | 8,318 | low |